We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
(-2.6%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$105M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$103M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$97.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$77.4M |
| 5 |
Humana
HUM
|
+$71.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$125M |
| 2 |
Perrigo
PRGO
|
+$103M |
| 3 |
AGN
Allergan plc
AGN
|
+$99.6M |
| 4 |
Pfizer
PFE
|
+$90M |
| 5 |
Viatris
VTRS
|
+$88.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.63% |
| 2 | Healthcare | 15.57% |
| 3 | Communication Services | 13.26% |
| 4 | Technology | 11.56% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JOY
501
DELISTED
Joy Global Inc
JOY
| $2.57M | 0.02% |
160,062
-2,663
| -2% | -$33.5K |
|
|
CRC
502
DELISTED
California Resources Corporation
CRC
| $2.56M | 0.02% |
248,984
-8,201
| -3% | -$96.8K |
|
503
Globe Life
GL
$13.5B
| $2.56M | 0.02% |
47,299
+40,791
| +627% | +$2.17M |
|
504
Automatic Data Processing
ADP
$100B
| $2.56M | 0.02% |
+28,481
| New | +$2.39M |
|
505
Haemonetics
HAE
$3.58B
| $2.55M | 0.02% |
+72,771
| New | +$2.35M |
|
506
West Pharmaceutical
WST
$23.1B
| $2.53M | 0.02% |
+36,438
| New | +$2.19M |
|
|
CTRA
507
DELISTED
Coterra Energy
CTRA
| $2.51M | 0.02% |
110,654
-33,105
| -23% | -$664K |
|
|
CLNY
508
DELISTED
Colony Capital, Inc.
CLNY
| $2.51M | 0.02% |
+149,823
| New | +$2.52M |
|
|
MFLX
509
DELISTED
MULTI-FINELINE ELECTRONIX INC
MFLX
| $2.5M | 0.02% |
+107,861
| New | +$2.16M |
|
|
STOR
510
DELISTED
STORE Capital Corporation
STOR
| $2.49M | 0.02% |
+96,300
| New | +$2.36M |
|
|
QPACU
511
DELISTED
Quinpario Acquisition Corp. 2 Unit
QPACU
| $2.48M | 0.02% |
250,000
| – | – |
|
512
SPDR Gold Trust
GLD
$131B
| $2.47M | 0.02% |
+21,012
| New | +$2.38M |
|
513
BWX Technologies
BWXT
$16B
| $2.46M | 0.02% |
+73,158
| New | +$2.26M |
|
514
Grupo Aeroportuario del Sureste
ASR
$8.03B
| $2.45M | 0.02% |
+16,331
| New | +$2.23M |
|
|
MASI
515
DELISTED
Masimo
MASI
| $2.45M | 0.02% |
+58,609
| New | +$2.2M |
|
516
Super Micro Computer
SMCI
$19.5B
| $2.44M | 0.02% |
+716,070
| New | +$2.14M |
|
517
Orthofix Medical
OFIX
$455M
| $2.44M | 0.02% |
58,640
+21,827
| +59% | +$856K |
|
518
Capri Holdings
CPRI
$1.77B
| $2.42M | 0.02% |
42,511
+6,171
| +17% | +$305K |
|
|
MON
519
DELISTED
Monsanto Co
MON
| $2.4M | 0.02% |
27,311
-137,071
| -83% | -$12.4M |
|
520
Huntsman Corp
HUN
$2.24B
| $2.4M | 0.02% |
180,046
-304,259
| -63% | -$3.14M |
|
521
Check Point Software Technologies
CHKP
$13.3B
| $2.39M | 0.02% |
+27,300
| New | +$2.19M |
|
|
DMK
522
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $2.39M | 0.02% |
5,560
-1,399
| -20% | -$500K |
|
|
ELGX
523
DELISTED
Endologix Inc
ELGX
| $2.37M | 0.02% |
28,380
+25,363
| +841% | +$2.09M |
|
524
Middleby
MIDD
$6.05B
| $2.37M | 0.02% |
22,152
-701
| -3% | -$65.9K |
|
|
CSRA
525
DELISTED
CSRA Inc.
CSRA
| $2.36M | 0.02% |
+87,740
| New | +$2.29M |
|
Similar funds
Marshall Wace's Q1 2016 Portfolio in Review
As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.
- Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
- Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
- Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
- Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
- Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
- Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.
Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.